Regulation of wound healing and fibrosis by hypoxia and hypoxia-inducible factor-1

Molecules and Cells

Volumn 37, Issue 9, 2014, Pages 637-643

  Ruthenborg, Robin J ^a   Ban, Jae Jun ^a   Wazir, Anum ^a   Takeda, Norihiko ^b   Kim, Jung Whan ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Fibrosis; Hypoxia; Hypoxia inducible factor 1; Oxygen; Wound healing

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1;

DIABETES MELLITUS; FIBROSIS; HUMAN; HYPOXIA; NONHUMAN; REVIEW; WOUND HEALING; ANIMAL; ANOXIA; CELL HYPOXIA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANOXIA; CELL HYPOXIA; DIABETES MELLITUS; FIBROSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84919457239     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.0150     Document Type: Review

References (60)

1. Ahluwalia, A., and Tarnawski, A.S. (2012). Critical role of hypoxia sensor--HIF-1alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr. Med. Chem. 19, 90-97.
2. Andrikopoulou, E., Zhang, X., Sebastian, R., Marti, G., Liu, L., Milner, S.M., and Harmon, J.W. (2011). Current Insights into the role of HIF-1 in cutaneous wound healing. Curr. Mol. Med. 11, 218-235.
3. Asada, N., Takase, M., Nakamura, J., Oguchi, A., Asada, M., Suzuki, N., Yamamura, K., Nagoshi, N., Shibata, S., Rao, T.N., et al. (2011). Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J. Clin. Invest. 121, 3981-3990.
4. Barriga, E.H., Maxwell, P.H., Reyes, A.E., and Mayor, R. (2013). The hypoxia factor Hif-1alpha controls neural crest chemotaxis and epithelial to mesenchymal transition. J. Cell Biol. 201, 759-776.
5. Basu, R.K., Hubchak, S., Hayashida, T., Runyan, C.E., Schumacker, P.T., and Schnaper, H.W. (2011). Interdependence of HIF-1alpha and TGF-beta/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am. J. Physiol. Renal Physiol. 300, F898-905.
6. Berra, E., Roux, D., Richard, D.E., and Pouyssegur, J. (2001). Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm. EMBO Rep. 2, 615-620.
7. Beuck, S., Schanzer, W., and Thevis, M. (2012). Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesisstimulating agents in current and preventive doping analysis. Drug Test. Anal. 4, 830-845.
8. Botusan, I.R., Sunkari, V.G., Savu, O., Catrina, A.I., Grunler, J., Lindberg, S., Pereira, T., Yla-Herttuala, S., Poellinger, L., Brismar, K., et al. (2008). Stabilization of HIF-1 alpha is critical to improve wound healing in diabetic mice. Proc. Natl. Acad. Sci. USA 105, 19426-19431.
9. Catrina, S.B., Okamoto, K., Pereira, T., Brismar, K., and Poellinger, L. (2004). Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes 53, 3226-3232.
10. Ceradini, D.J., and Gurtner, G.C. (2005). Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc. Med. 15, 57-63.
11. Ceradini, D.J., Kulkarni, A.R., Callaghan, M.J., Tepper, O.M., Bastidas, N., Kleinman, M.E., Capla, J.M., Galiano, R.D., Levine, J.P., and Gurtner, G.C. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864.
12. Cramer, T., Yamanishi, Y., Clausen, B.E., Forster, I., Pawlinski, R., Mackman, N., Haase, V.H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003). HIF-1 alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645-657.
13. De Luca, M., Pellegrini, G., Zambruno, G., and Marchisio, P.C. (1994). Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies. J. Dermatol. 21, 821-828.
14. Elson, D.A., Ryan, H.E., Snow, J.W., Johnson, R., and Arbeit, J.M. (2000). Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 60, 6189-6195.
15. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D., and Semenza, G.L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613.
16. Gao, W., Ferguson, G., Connell, P., Walshe, T., Murphy, R., Birney, Y.A., O’Brien, C., and Cahill, P.A. (2007). High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway. J. Mol. Cell. Cardiol. 42, 609-619.
17. Higgins, D.F., Kimura, K., Bernhardt, W.M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R.S., Kretzler, M., Cohen, C.D., et al. (2007). Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117, 3810-3820.
18. Hoffman, E.C., Reyes, H., Chu, F.F., Sander, F., Conley, L.H., Brooks, B.A., and Hankinson, O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252, 954-958.
19. Hong, W.X., Hu, M.S., Esquivel, M., Liang, G.Y., Rennert, R.C., McArdle, A., Paik, K.J., Duscher, D., Gurtner, G.C., Lorenz, H.P., et al. (2014). The Role of Hypoxia-Inducible Factor in Wound Healing. Adv. Wound Care 3, 390-399.
20. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J.M., Lane, W.S., and Kaelin, W.G., Jr. (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464-468.
21. Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J., Gaskell, S.J., von Kriegsheim, A., Hebestreit, H.F., Mukherji, M., Schofield, C.J., et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472.
22. Kalucka, J., Ettinger, A., Franke, K., Mamlouk, S., Singh, R.P., Farhat, K., Muschter, A., Olbrich, S., Breier, G., Katschinski, D.M., et al. (2013). Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice. Mol. Cell. Biol. 33, 3426-3438.
23. Kaminski, N., and Rosas, I.O. (2006). Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes? Proc. Am. Thorac. Soc. 3, 339-344.
24. Kim, J.W., Tchernyshyov, I., Semenza, G.L., and Dang, C.V. (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metabol. 3, 177-185.
25. Kimura, K., Iwano, M., Higgins, D.F., Yamaguchi, Y., Nakatani, K., Harada, K., Kubo, A., Akai, Y., Rankin, E.B., Neilson, E.G., et al. (2008). Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am. J. Physiol. Renal Physiol. 295, F1023-1029.
26. Koch, L.G., and Britton, S.L. (2008). Aerobic metabolism underlies complexity and capacity. J. Physiol. 586, 83-95.
27. Kottmann, R.M., Kulkarni, A.A., Smolnycki, K.A., Lyda, E., Dahanayake, T., Salibi, R., Honnons, S., Jones, C., Isern, N.G., Hu, J.Z., et al. (2012). Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pHdependent activation of transforming growth factor-beta. Am. J. Respir. Crit. Care Med. 186, 740-751.
28. Labrecque, M.P., Prefontaine, G.G., and Beischlag, T.V. (2013). The aryl hydrocarbon receptor nuclear translocator (ARNT) family of proteins: transcriptional modifiers with multi-functional protein interfaces. Curr. Mol. Med. 13, 1047-1065.
29. Lee, K., and Nelson, C.M. (2012). New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis. Int. Rev. Cell Mol. Biol. 294, 171-221.
30. Li, J., Chen, J., and Kirsner, R. (2007). Pathophysiology of acute wound healing. Clin. Dermatol. 25, 9-18.
31. Lokmic, Z., Musyoka, J., Hewitson, T.D., and Darby, I.A. (2012). Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int. Rev. Cell Mol. Biol. 296, 139-185.
32. Loomis-King, H., Flaherty, K.R., and Moore, B.B. (2013). Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis. Curr. Opin. Pharmacol. 13, 377-385.
33. Maher, T.M. (2012). Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment. Clin. Chest Med. 33, 69-83.
34. Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R., and Ratcliffe, P.J. (1999). The tumour suppressor protein VHLtargets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
35. Moulik, P.K., Mtonga, R., and Gill, G.V. (2003). Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 26, 491-494.
36. Murdoch, C., Muthana, M., and Lewis, C.E. (2005). Hypoxia regulates macrophage functions in inflammation. J. Immunol. 175, 6257-6263.
37. Myllyharju, J. (2009). HIF prolyl 4-hydroxylases and their potential as drug targets. Curr. Pharm. Des. 15, 3878-3885.
38. Myllyharju, J. (2013). Prolyl 4-hydroxylases, master regulators of the hypoxia response. Acta Physiol. 208, 148-165.
39. Noble, P.W., Barkauskas, C.E., and Jiang, D.H. (2012). Pulmonary fibrosis: patterns and Perpetrators. J. Clin. Invest. 122, 2756-2762.
40. Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., Huang, L.E., Pavletich, N., Chau, V., and Kaelin, W.G. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423-427.
41. Pan, X., Suzuki, N., Hirano, I., Yamazaki, S., Minegishi, N., and Yamamoto, M. (2011). Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice. PLoS One 6, e25839.
42. Pichiule, P., Chavez, J.C., and LaManna, J.C. (2004). Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J. Biol. Chem. 279, 12171-12180.
43. Remensnyder, J.P., and Majno, G. (1968). Oxygen gradients in healing wounds. Am. J. Pathol. 52, 301-323.
44. Schafer, M., and Werner, S. (2008). Oxidative stress in normal and impaired wound repair. Pharmacol. Res. 58, 165-171.
45. Semenza, G.L. (2012). Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408.
46. Semenza, G.L., and Wang, G.L. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454.
47. Taraboletti, G., D’Ascenzo, S., Giusti, I., Marchetti, D., Borsotti, P., Millimaggi, D., Giavazzi, R., Pavan, A., and Dolo, V. (2006). Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 8, 96-103.
48. Taylor, C.T., and McElwain, J.C. (2010). Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans. Physiology 25, 272-279.
49. Tepper, O.M., Capla, J.M., Galiano, R.D., Ceradini, D.J., Callaghan, M.J., Kleinman, M.E., and Gurtner, G.C. (2005). Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 105, 1068-1077.
50. Thangarajah, H., Vial, I.N., Grogan, R.H., Yao, D.C., Shi, Y.B., Januszyk, M., Galiano, R.D., Chang, E.I., Galvez, M.G., Glotzbach, J.P., et al. (2010). HIF-1 alpha dysfunction in diabetes. Cell Cycle 9, 75-79.
51. Tuder, R.M., Lara, A.R., and Thannickal, V.J. (2012). Lactate, a novel trigger of transforming growth factor-beta activation in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 186, 701-703.
52. Tzouvelekis, A., Harokopos, V., Paparountas, T., Oikonomou, N., Chatziioannou, A., Vilaras, G., Tsiambas, E., Karameris, A., Bouros, D., and Aidinis, V. (2007). Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis. Am. J. Respir. Crit. Care Med. 176, 1108-1119.
53. Wang, G.L., and Semenza, G.L. (1993). Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268, 21513-21518.
54. Wang, G.L., Jiang, B.H., Rue, E.A., and Semenza, G.L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92, 5510-5514.
55. Watson, C.J., Collier, P., Tea, I., Neary, R., Watson, J.A., Robinson, C., Phelan, D., Ledwidge, M.T., McDonald, K.M., McCann, A., et al. (2014). Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype. Hum. Mol. Genet. 23, 2176-2188.
56. Weidemann, A., and Johnson, R.S. (2008). Biology of HIF-1 alpha. Cell Death Differ. 15, 621-627.
57. Yamakawa, M., Liu, L.X., Date, T., Belanger, A.J., Vincent, K.A., Akita, G.Y., Kuriyama, T., Cheng, S.H., Gregory, R.J., and Jiang, C. (2003). Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ. Res. 93, 664-673.
58. Zeisberg, M., and Kalluri, R. (2013). Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am. J. Physiol. Cell Physiol. 304, C216-C225.
59. Zhang, H., Akman, H.O., Smith, E.L., Zhao, J., Murphy-Ullrich, J.E., and Batuman, O.A. (2003). Cellular response to hypoxia involves signaling via Smad proteins. Blood 101, 2253-2260.
60. Zhang, X., Yan, X., Cheng, L., Dai, J., Wang, C., Han, P., and Chai, Y. (2013). Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice. PLoS One 8, e84548.